US2020022893A1PendingUtilityA1

Skincare Formulations and Regimens

33
Assignee: STELLA & DOT LLCPriority: Nov 3, 2014Filed: Feb 22, 2019Published: Jan 23, 2020
Est. expiryNov 3, 2034(~8.3 yrs left)· nominal 20-yr term from priority
Inventors:Christin Powell
A61P 43/00A61P 17/18A61K 8/9706A61K 8/64A61K 8/9728A61K 8/4953A61Q 19/08A61K 8/347A61K 8/361A61K 8/4946A61K 8/27A61Q 19/02A61Q 17/04A61K 8/29A61K 8/9789A61K 8/735A61K 8/9794A61K 8/97
33
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided are compositions, comprising a neolignan, ectoin, and a molecule of Formula I: wherein R 1 , R 2 and R 3 are independently H, methyl, ethyl, propyl, or isopropyl; wherein X is S or O. In some cases, the molecule of Formula I is ergothioneine (EGT). In some cases, the at least one neolignan is honokiol or a derivative thereof. Honokiol may be provided in the form of magnolia bark extract. Methods of making and using these compositions are also provided.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A composition comprising:
 ectoin; and   a molecule of Formula I:   
       
         
           
           
               
               
           
         
         wherein R 1 , R 2  and R 3  are independently H, methyl, ethyl, propyl, or isopropyl; and 
         wherein X is S or O.

Join the waitlist — get patent alerts

Track US2020022893A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.